MAXCYTE INC. - COMMON
3.3800
26-November-24 15:45:00
15 minutes delayed
Stocks
-0.2300
-6.37%
Today's range
3.3300 - 3.6100
ISIN
N/A
Source
NASDAQ
-
12 Apr 2022 15:05:00 By Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 Mar 2022 15:05:01 By Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 Mar 2022 15:15:00 By Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Feb 2022 16:00:00 By Nasdaq GlobeNewswire
-
01 Feb 2022 01:00:00 By Nasdaq GlobeNewswire
-
MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results
24 Jan 2022 01:30:00 By Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
12 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter Financial Results
10 Nov 2021 15:00:00 By Nasdaq GlobeNewswire
-
MaxCyte Board Member Richard Douglas, PhD, Appointed Chairman of the Board
03 Nov 2021 08:00:02 By Nasdaq GlobeNewswire
-
29 Oct 2021 11:40:00 By Nasdaq GlobeNewswire
-
28 Oct 2021 09:00:00 By Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
25 Oct 2021 15:30:00 By Nasdaq GlobeNewswire
-
MaxCyte Set to Join Russell 2000® Index
17 Sep 2021 07:35:00 By Nasdaq GlobeNewswire
-
13 Sep 2021 15:05:00 By Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021
02 Sep 2021 07:05:00 By Nasdaq GlobeNewswire